ArticleKidney diseases (Basel, Switzerland)
Monthly versus Bimonthly Bioelectrical Impedance Analysis for Dry Weight Assessment and Intradialytic Hypotension: A Randomized Crossover Trial.
Article in Kidney diseases (Basel, Switzerland). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Intradialytic hypotension (IDH) is a major complication during hemodialysis (HD), leading to arrhythmias and increased mortality. Inaccurate dry weight (DW) adjustment contributes to IDH. Bioelectrical impedance analysis (BIA) is commonly used to assess body composition, including fluid compartments, aiding in DW measurement. However, the measurement interval of BIA measurement to reduce IDH remains unclear. Methods: This single-center, randomized crossover trial enrolled 94 end-stage kidney disease patients on HD, and 82 of them completed the protocol. Participants were divided into two groups: group 1 underwent BIA monthly for 4 months, then bimonthly twice; group 2 started with BIA bimonthly twice, then monthly for 4 months. A 1-month washout period was implemented before switching measurement frequencies. The primary outcome was to determine if bimonthly BIA reduced IDH as effectively as monthly BIA. Secondary outcomes assessed factors influencing IDH. Results: No significant different incidence rate of IDH between monthly and bimonthly BIA measurement frequencies in both per-protocol (0.044 and 0.046 per patient treatment, respectively, Conclusion: There was no significant difference in the incidence rate of IDH between monthly and bimonthly BIA measurements.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.